AbbVie Inc -- Physician Payments Report

Spending Summary

AbbVie Inc has made $13,498,182.90 in total payments to 0 physicians across 897 recorded transactions.

• Total Physician Spending: $13,498,182.90
• Total Physicians Paid: 0
• Total Payment Transactions: 897
• Spending Aggressiveness Score: 50/100 -- This score reflects the overall spending intensity relative to industry peers. A higher score indicates more aggressive physician payment patterns.

AI Spending Analysis

The following analysis was generated by artificial intelligence based on AbbVie Inc's payment history, specialty targeting patterns, and industry comparisons. This analysis is not medical or legal advice.

AbbVie Inc., a global biopharmaceutical company, demonstrates a significant financial engagement with healthcare professionals, as evidenced by its reported total physician payments of $326,927.79 across 28 recorded transactions. While the exact number of unique doctors paid is unknown from the provided data, the distribution of these payments highlights strategic targeting of specific medical specialties. Neurology leads the pack with $95,221.96 distributed across 6 payments, followed closely by Rheumatology at $81,427.80 for 11 payments, and Oncology with $62,181.71 across 5 payments. Dermatology and Gastroenterology also feature, receiving $53,765.06 (4 payments) and $34,331.26 (2 payments) respectively. This focus suggests AbbVie's primary therapeutic areas of interest and the specialties whose insights and influence are deemed most valuable for their product portfolios, likely including treatments for autoimmune diseases (rheumatology), neurological disorders, and various cancers (oncology). The geographic focus is not explicitly detailed in the provided data, but the nature of these payments often reflects areas with high patient populations for the targeted conditions. The provided data does not break down payments by type (e.g., consulting, speaking, research, meals), making a detailed analysis of payment categories impossible. Comparing AbbVie's spending to industry peers requires broader market data, but the reported figures indicate a substantial investment in physician relationships. For patients, understanding these relationships is crucial. Payments to physicians can facilitate the dissemination of information about new treatments, support medical education, and fund research. However, it is essential for patients to be aware that such financial ties exist, as they could potentially influence prescribing patterns. Transparency in these payments, as mandated by programs like CMS Open Payments, allows patients to make more informed decisions about their healthcare and to have open discussions with their doctors about potential conflicts of interest and the rationale behind treatment choices. Patients should always feel empowered to ask their physicians about any financial relationships they may have with pharmaceutical companies and how these relationships might inform their medical recommendations.

Medical Specialties Targeted by AbbVie Inc

The following medical specialties receive the most payments from AbbVie Inc. Understanding which specialties a company targets can provide insight into their product portfolio and marketing strategy.

Top Physicians Paid by AbbVie Inc

The following physicians have received the largest payments from AbbVie Inc. Click on a physician's name to view their complete payment report.

Recent Payment Records

The following table shows the most recent payments from AbbVie Inc to physicians as recorded in the CMS Open Payments database.

Frequently Asked Questions About AbbVie Inc

How much does AbbVie Inc spend on doctors?

AbbVie Inc. reported a total of $326,927.79 in physician payments across 28 transactions. The specific number of unique physicians paid is not detailed in the provided data. This spending is concentrated in key therapeutic areas, reflecting strategic engagement with healthcare providers who treat patients within these specialties.

Which doctors receive the most from AbbVie Inc?

Based on the provided recent payments, Dr. Rachel Parker received $42,223.99, Dr. Paul Turner received $33,571.91, and Dr. Jennifer Patel received $25,928.94. These payments are associated with specialties like Rheumatology, Neurology, and Dermatology, indicating a focus on physicians in these fields.

What specialties does AbbVie Inc target?

AbbVie Inc. primarily targets Neurology ($95,221.96), Rheumatology ($81,427.80), and Oncology ($62,181.71). These areas likely align with AbbVie's key drug portfolios, such as treatments for autoimmune conditions, neurological disorders, and cancer therapies. The significant investment suggests a strategy to engage with specialists who manage these complex patient populations.

Is AbbVie Inc spending more or less than average?

The provided data offers a snapshot of AbbVie Inc.'s spending but does not include comparative figures against industry peers or an overall average. To determine if their spending is higher or lower than average, a broader analysis of pharmaceutical industry payment data across multiple companies would be necessary.

Should I be concerned if my doctor takes money from AbbVie Inc?

It is important for patients to be aware of any financial relationships their doctor may have with pharmaceutical companies like AbbVie Inc. These payments can support medical education and research. However, transparency is key. Patients should feel comfortable discussing these relationships with their doctor to understand how it might inform treatment recommendations and to ensure that their best interests remain the primary focus of care.

What types of payments does AbbVie Inc make?

The provided data does not specify the types of payments made by AbbVie Inc. to physicians. Such payments can include consulting fees, speaking engagements, research grants, meals, travel, and other forms of compensation. A detailed breakdown of payment categories would require access to more granular data from sources like the CMS Open Payments database.

Does AbbVie Inc have a history of marketing violations?

Information regarding AbbVie Inc.'s history of marketing violations is not included in the provided physician payment data. To assess this, one would need to consult regulatory databases and public records from agencies like the FDA or Department of Justice, which track enforcement actions and settlements related to pharmaceutical marketing practices.

Understanding Pharmaceutical Company Payment Reports

Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. AbbVie Inc is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.

A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.

Related Resources

• Search for other pharmaceutical companies or doctors
• Browse pharmaceutical payments by medical specialty
• Browse pharmaceutical payments by state